The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Marchenkova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Dreval' A.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Kriukova I.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Vishniakova M.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Poliakova E.Iu.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Tishenina R.S.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Rubin M.P.

GKB #23 im. Medsantrud, Moskva

Efficacy and safety of Bivalos therapy in patients with postmenopausal osteoporosis without calcium and vitamin D supplement

Authors:

Marchenkova L.A., Dreval' A.V., Kriukova I.V., Vishniakova M.V., Poliakova E.Iu., Tishenina R.S., Rubin M.P.

More about the authors

Journal: Problems of Endocrinology. 2010;56(1): 35‑41

Views: 989

Downloaded: 12

Download PDF (RU)
Contact the author
Table of contents

EFFICACY AND SAFETY OF BIVALOS THERAPY IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS WITHOUT CALCIUM AND VITAMIN D SUPPLEMENT
EFFICACY AND SAFETY OF BIVALOS THERAPY IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS WITHOUT CALCIUM AND VITAMIN D SUPPLEMENT

To cite this article:

Marchenkova LA, Dreval' AV, Kriukova IV, Vishniakova MV, Poliakova EIu, Tishenina RS, Rubin MP. Efficacy and safety of Bivalos therapy in patients with postmenopausal osteoporosis without calcium and vitamin D supplement. Problems of Endocrinology. 2010;56(1):35‑41. (In Russ.)

МСФ на ЯМ
Close metadata
Recommended articles:
Human diseases treatment via enema fecal microbiota transplantation. Methodological reco­mmendations. Russian Journal of Preventive Medi­cine. 2024;(6):79-87
Cognitive beha­vioral therapy in the treatment of patients with chro­nic migraine and concomitant chro­nic inso­mnia: a prospective, randomized trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):110-117
Late-onset schi­zophrenia and schi­zophrenia-like psychosis with very late onset. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):32-40
Calcium-phosphorus meta­bolism and assi­sted reproductive technologies: inte­rsection points. Russian Journal of Human Reproduction. 2024;(4):19-28
Correlation between vita­min D level and autoimmune and non-autoimmune bullous dermatosis. Approaches to adju­vant treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):565-573
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Asso­ciation between the vita­min D level and depression in the elde­rly people in the Euro­pean North of Russia. Russian Journal of Preventive Medi­cine. 2024;(12):107-113
The asso­ciation of NOS1AP gene poly­morphisms with the dura­tion of the QT inte­rval in patients with schi­zophrenia receiving anti­psychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104
Vita­min D role in oral cavity diseases. Stomatology. 2025;(1):81-86
Characteristics, treatment features and in-hospital mortality of patients with myocardial infa­rction over 75 years old in Russia acco­rding to the REGION-IM regi­stry. Russian Cardiology Bulletin. 2025;(1):22-38

Keywords:

postmenopausal osteoporosis
vitamin D
therapy

Authors:

Marchenkova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Dreval' A.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Kriukova I.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Vishniakova M.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Poliakova E.Iu.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Tishenina R.S.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Rubin M.P.

GKB #23 im. Medsantrud, Moskva

List of references:

  1. Bell N.H., Bilezikian J.P. et al. Alendronate increases bone mass and reduces markers in postmenopausal African-American women J Clin Endocrinol Metabol 2002; 87: 6: 2792-2797.
  2. Black D.M., Delmas P.D., Estell R. et al. Once-early zoledronic acid for treatment of postmenopausal octeoporosis. N Engl J Med 2007; 356: 1809-1822.
  3. Neer R.M., Arnaud C.D., Zanchetta J.R. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. Engl J Med 2001; 35: 1434-1441.
  4. Caverzasio J. et al. Strontium ranelate increases osteoblast replication through activation of an original cellular mechanism. Calcified Tissue Int 2007; 80 (suppl 1): S74.
  5. Canalis E., Hott M. et al. The divalent strontium solt S12911 enhances bone cell replication and bone formation in vitro. Bone 1996: 18: 517-523.
  6. Atkins G.J., Welldon K.J., Findlay D.M. et al. Strontium ranelate promotes an osteocyte-like phenotype from human primary osteoblasts ex vivo. Calcified Tissue Int 2007; 80 (suppl 1): 71-72.
  7. Rozhinskaya L.Ya., Belyaeva A.V., Belaya Zh.E. Ranelat strontsiya (Bivalos) - preparat dvoinogo deistviya na kostnuyu tkan'; novye podkhody k lecheniyu osteoporoza. Osteoporoz i osteopatii 2006; 1: 32-37.
  8. Osteoporoz: diagnostika, profilaktika i lechenie (klinicheskie rekomendatsii). Pod red. O.M. Lesnyak, L.I. Benevolenskoi 2-e izd. M: GEOTAR-Media 2009; 272.
  9. Marquis P., Roux C., de la Loge C. et al. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteopor Int 2008; 19: 4: 503-510.
  10. Meunier P.J., Roux C., Seeman E. et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New Eng J Med 2004; 350: 459-468.
  11. Reginster J..Y, Seeman E., De Vernejoul M.C. et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005; 90: 5: 2816-2822.
  12. Rizzoli R., Boonen S., Brandi M.L. et al. The role of calcium and vitamin D in the management of osteoporosis. Bone 2008; 42: 246-249.
  13. Lips P., Cooper C., Agnusdei D. et al. Quality of life in patients with vertebral fractures: validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteopor Int 1999; 10: 150-160. doi: 10.1007 s001980050210.
  14. Lips P., Cooper C. Qualeffo-41 scoring algorithm (updated 31.10.2005). Available from: http://www.iofbonehealth.org.
  15. Bruyère O., Roux C., Detilleux J. et al. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 2007; 92: 8: 3076-3081.
  16. Rozhinskaya L.Ya., Arapova S.D., Dzeranova L.K. i dr. Rezul'taty rossiiskogo mnogotsentrovogo issledovaniya effektivnosti i perenosimosti Bivalosa (strontsiya ranelata) u zhenshchin s postmenopauzal'nym osteoporozom. Osteoporoz i osteopatii 2007; 3: 24-30.
  17. Dreval' A.V., Marchenkova L.A., Kryukova I.V. i dr. Effektivnost', perenosimost' i komplaentnost' alendronata natriya (70 mg 1 raz v nedelyu) pri lechenii postmenopauzal'nogo osteoporoza. Osteoporoz i osteopatii 2006; 2: 13-17.
  18. Rizzoli R., Greenspan S.L. at al. Two-years results of onse-weekly administration of Alendronate 70 mg for the treatment of postmenopausal osteoporosis J Bone Min Res 2002; 17: 1988-1996.
  19. Massari F., Zanchetta S.R. et al. PTH levels in posmenopausal women with osteoporosis treated with alendronate. J Bone Min Res 1997; 12 (Suppl 1): 4

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.